TNXP
Tonix Pharmaceuticals Holding Corp
Price:  
1.19 
USD
Volume:  
931,270.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TNXP WACC - Weighted Average Cost of Capital

The WACC of Tonix Pharmaceuticals Holding Corp (TNXP) is 5.5%.

The Cost of Equity of Tonix Pharmaceuticals Holding Corp (TNXP) is 9.65%.
The Cost of Debt of Tonix Pharmaceuticals Holding Corp (TNXP) is 5.00%.

Range Selected
Cost of equity 8.30% - 11.00% 9.65%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.1% - 5.9% 5.5%
WACC

TNXP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.96 1.09
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.30% 11.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 2.3 2.3
Cost of debt 5.00% 5.00%
After-tax WACC 5.1% 5.9%
Selected WACC 5.5%